Research Status Research on BPC-157 is currently at an advanced preclinical stage, with a scientific literature comprising more than 100 peer-reviewed publications
Future improvements can be made through the implementation of personalized treatment protocols, the conduct of multi-center clinical trials, and the application of cutting-edge technologies, among other multi-dimensional improvement measures
This observation implies that the combined use of cisplatin and mTOR inhibitors could be a viable approach to surmount cisplatin resistance in ovarian cancer treatment
Animal studies and observations in acromegalic patients demonstrate that GH-excess can have deleterious effects on kidney health, including glomerular hyperfiltration, renal hypertrophy, and glomerulosclerosis
Reviewed submitted version of manuscript: both authors
This supports overall liver health and function, potentially reducing the risk of liver diseases